(opens in a new window)

Clyde E. Markowitz, MD

Associate Professor of Neurology at the Hospital of the University of Pennsylvania

Department: Neurology


Contact Information

Hospital of the University of Pennsylvania
3 West Gates Building
3400 Spruce Street

Philadelphia, PA 19104
Office: 215-662-4521
Fax: 215-349-5579
Email: cmarkowi@pennmedicine.upenn.edu


I3H Keywords

  • Autoimmunity

Education

  • B.S. (Business Administration)
    State University of New York at Buffalo, 1982
  • (Post-baccalaureate pre-med program)
    Columbia University, 1986
  • M.D. (Medicine)
    Columbia Univ. College of Physicians & Surgeons, 1990

Post-Graduate Training

  • Internal Medicine
    Columbia-Presbyterian Medical Center New York, N.Y., 1990 - 1991
  • Resident in Neurology
    Neurological Institute-Columbia-Presbyterian Medical Center New York, N.Y. , 1991 - 1994
  • Neuroimmunology/MS-Research/Clinical Postdoc. Fellowship
    Neurological Institute- Columbia-Presbyterian Medical Center New York, N.Y., 1994 - 1998

Certifications

  • National Board of Medical Examiners, 1991
  • American Board of Psychiatry and Neurology, 1995
  • American Board of Psychiatry and Neurology- Recertification, 2005

Description of ITMAT Expertise

MRI in MS

Selected Publications

  • Fox EJ, Markowitz C, Applebee A, Montalban X, Wolinsky JS, Belachew S, Fiore D, Pei J, Musch B, Giovannoni G : Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial. Mult Scler. November 2018
  • Cehelyk EK, Harvey DY, Grubb ML, Jalel R, El-Sibai MS, Markowitz CE, Berger JR, Hamilton RH, Chahin S : Uncovering the association between fatigue and fatigability in multiple sclerosis using cognitive control. Mult Scler Relat Disord. 27 : 269-275, October 2018
  • Fox E, Markowitz C, Applebee A, et al : Effect of ocrelizumab on upper limb function in patients with primary progressive multiple sclerosis (PPMS) in the oratorio study (ENCORE) J Neurol Neurosurg Psychiatry 89(A14) 2018
  • Sahin N, Selouan R, Markowitz CE, Melhem ER, Bilello M : Limbic pathway lesions in patients with multiple sclerosis. Acta Radiol. 57(3) : 341-7, March 2016
  • Salim Chahin, MD; Deborah Miller, PhD; Reiko Sakai; James Wilson; Clyde Markowitz, MD; Dina Jacobs, MD; Ari Green, MD; Peter A. Calabresi, MD; Elliot M. Frohman, MD; Steven Galetta, MD; Laura Balcer, MD, MSCE: : Fatigue in Multiple Sclerosis: Relation to Quantitative Neurologic and Visual Outcomes. Multiple Sclerosis and related disorders May 2015
  • Jose Torres, Amy Pruitt, Laura Balcer, Steven Galetta, Clyde Markowitz, Nabila Dahodwala : Analysis of the treatment of neuromyelitis optica Journal of the Neurological Sciences 351(1) Feb 2015
  • Salim Chahin, Deborah Miller, Reiko E. Sakai, James A. Wilson, Teresa Frohman, Clyde Markowitz, Dina Jacobs, Ari Green, Peter A. Calabresi, Elliot M. Frohman, Steven L. Galetta, Laura J. Balcer : Relation of quantitative Visual and neurologic outcomes to fatigue in multiple sclerosis Multiple Sclerosis and Related Disorders 4(4) 2015
  • Edward Fox, Barbara Green, Clyde Markowitz, Ronald Murray, Andrew D Goodman, Stephen J Glenski, Pippa Loupe, Jo Nita Cogburn : The effect of scheduled antibody testing on treatment patterns in interferon-treated patients with multiple sclerosis BMC Neurology 14(1) april 2014
  • Patricia K Coyle, Bruce A Cohen, Thomas Leist, Clyde Markowitz, Merrikay Oleen-Burkey, Marc Schwartz, Mark J Tullman, Howard Zwibel : Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes BMC Neurology 14(1) March 2014
  • Miller Aaron E, Cohen Bruce A, Krieger Stephen C, Markowitz Clyde E, Mattson David H, Tselentis Helen N : Constructing an adaptive care model for the management of disease-related symptoms throughout the course of multiple sclerosis--performance improvement CME. Multiple sclerosis (Houndmills, Basingstoke, England) Aug 2013